BioPharmX Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 7

  • Investments
  • 2

BioPharmX General Information

Description

BioPharmX Corp specialty pharmaceutical company engaged in utilizing its proprietary drug delivery technologies to develop and commercialize novel prescription products that address large markets in dermatology. Its objective is to develop products that treat health or age-related conditions that are not presently being addressed or treated with drug therapies or drug delivery approaches that are sub-optimal. The company has developed its product portfolio using its proprietary drug delivery technologies, including delivery mechanisms for antibiotics, biologic materials, and molecular iodine. Its products include VI2OLET iodine dietary supplement, two clinical-stage product candidates, BPX01 and BPX03 and one development-stage product candidate, BPX02.

Contact Information

Website
www.biopharmx.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 900 E. Hamilton Avenue
  • Suite 100
  • Campbell, CA 95008
  • United States
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Trex Wind Down
Vertical(s)
LOHAS & Wellness
Corporate Office
  • 900 E. Hamilton Avenue
  • Suite 100
  • Campbell, CA 95008
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioPharmX Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioPharmX‘s full profile, request access.

Request a free trial

BioPharmX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
BioPharmX Corp specialty pharmaceutical company engaged in utilizing its proprietary drug delivery technologies to devel
Drug Delivery
Campbell, CA
3 As of 2020

Blue Ash, OH
 

Nashville, TN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioPharmX Competitors (14)

One of BioPharmX’s 14 competitors is Aprecia (Drug Delivery), a Venture Capital-Backed company based in Blue Ash, OH.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aprecia (Drug Delivery) Venture Capital-Backed Blue Ash, OH
Cumberland Pharmaceuticals Formerly VC-backed Nashville, TN
Charles River Laboratories International Formerly PE-Backed Wilmington, MA
Zylo Therapeutics Venture Capital-Backed Greenville, SC
Sol-Gel Technologies Formerly PE-Backed Ness Ziona, Israel
You’re viewing 5 of 14 competitors. Get the full list »

BioPharmX Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • Pending

  • Expiring in next 12 mo

BioPharmX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170304359-A1 Oral iodine dosage form Inactive 21-Apr-2016
CA-2980527-A1 Pharmaceutical tetracycline composition for dermatological use Inactive 23-Mar-2015
AU-2016235237-A1 Pharmaceutical tetracycline composition for dermatological use Active 23-Mar-2015
ES-2846882-T3 Pharmaceutical composition of tetracycline for dermatological use Active 23-Mar-2015
AU-2016235237-B2 Pharmaceutical tetracycline composition for dermatological use Inactive 23-Mar-2015 A61K9/0014
To view BioPharmX’s complete patent history, request access »

BioPharmX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioPharmX Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BioPharmX‘s full profile, request access.

Request a free trial

BioPharmX Acquisitions (2)

BioPharmX’s most recent deal was a Reverse Merger with Trex Wind Down. The deal was made on 18-May-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Trex Wind Down 18-May-2020 Reverse Merger Pharmaceuticals
Thompson Designs (Nevada) 23-Jan-2014 Merger/Acquisition Other Commercial Services
To view BioPharmX’s complete acquisitions history, request access »

BioPharmX Exits (1)

BioPharmX’s most recent exit was on 18-May-2020 from Trex Wind Down. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Trex Wind Down 18-May-2020 Completed
To view BioPharmX’s complete exits history, request access »

BioPharmX FAQs

  • When was BioPharmX founded?

    BioPharmX was founded in 2010.

  • Where is BioPharmX headquartered?

    BioPharmX is headquartered in Campbell, CA.

  • What is the size of BioPharmX?

    BioPharmX has 3 total employees.

  • What industry is BioPharmX in?

    BioPharmX’s primary industry is Drug Delivery.

  • Is BioPharmX a private or public company?

    BioPharmX is a Private company.

  • What is BioPharmX’s current revenue?

    The current revenue for BioPharmX is .

  • How much funding has BioPharmX raised over time?

    BioPharmX has raised $36.4M.

  • Who are BioPharmX’s investors?

    Franklin Mutual Advisers, Korea Investment Partners, Thompson Designs (Nevada), and Vivo Capital have invested in BioPharmX.

  • Who are BioPharmX’s competitors?

    Aprecia (Drug Delivery), Cumberland Pharmaceuticals, Charles River Laboratories International, Zylo Therapeutics, and Sol-Gel Technologies are some of the 14 competitors of BioPharmX.

  • When was BioPharmX acquired?

    BioPharmX was acquired on 18-May-2020.

  • Who acquired BioPharmX?

    BioPharmX was acquired by Trex Wind Down.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »